|
2025-04-04 |
2025-04-02 |
S
Sale
|
Ferguson Toby
Chief Medical Officer
Officer
|
10,086
-6.0%
3.43
USD 34,595
|
10,086
-6.0%
|
3.43
|
USD 34,595
|
|
|
2025-04-04 |
2025-04-02 |
S
Sale
|
Sandrock Alfred
President and CEO
Executive Director
|
10,885
-2.5%
3.43
USD 37,336
|
10,885
-2.5%
|
3.43
|
USD 37,336
|
|
|
2025-02-24 |
2025-02-20 |
S
Sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
3,305
-4.1%
4.26
USD 14,079
|
3,305
-4.1%
|
4.26
|
USD 14,079
|
|
|
2025-02-24 |
2025-02-20 |
S
Sale
|
Sandrock Alfred
President and CEO
Executive Director
|
11,702
-3.8%
4.24
USD 49,616
|
11,702
-3.8%
|
4.24
|
USD 49,616
|
|
|
2025-02-24 |
2025-02-20 |
S
Sale
|
Swartz Robin
COO & CBO
Officer
|
3,894
-3.8%
4.25
USD 16,550
|
3,894
-3.8%
|
4.25
|
USD 16,550
|
|
|
2025-02-12 |
2025-02-11 |
S
Sale
|
Swartz Robin
COO & CBO
Officer
|
6,950
-6.4%
4.45
USD 30,928
|
6,950
-6.4%
|
4.45
|
USD 30,928
|
|
|
2025-02-12 |
2025-02-11 |
S
Sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
5,413
-6.3%
4.45
USD 24,088
|
5,413
-6.3%
|
4.45
|
USD 24,088
|
|
|
2025-02-12 |
2025-02-11 |
PS
Planned sale
|
Sandrock Alfred
President & CEO
Officer
|
16,644
-5.1%
4.45
USD 74,066
|
16,644
-5.1%
|
4.45
|
USD 74,066
|
|
|
2025-02-12 |
2025-02-11 |
S
Sale
|
Fahey Sandell Jacquelyn
Chief Legal Officer
Officer
|
4,358
-5.1%
4.45
USD 19,393
|
4,358
-5.1%
|
4.45
|
USD 19,393
|
|
|
2025-01-15 |
2025-01-14 |
S
Sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
1,191
-1.4%
5.13
USD 6,110
|
1,191
-1.4%
|
5.13
|
USD 6,110
|
|
|
2025-01-15 |
2025-01-14 |
S
Sale
|
Swartz Robin
COO & CBO
Officer
|
3,087
-2.7%
5.09
USD 15,713
|
3,087
-2.7%
|
5.09
|
USD 15,713
|
|
|
2024-12-26 |
2024-12-23 |
PS
Planned sale
|
Swartz Robin
COO&CBO
Officer
|
6,500
-5.5%
5.65
USD 36,725
|
6,500
-5.5%
|
5.65
|
USD 36,725
|
|
|
2024-10-03 |
2024-10-02 |
S
Sale
|
Fahey Sandell Jacquelyn
Chief Legal Officer
Officer
|
5,999
-6.5%
5.82
USD 34,914
|
5,999
-6.5%
|
5.82
|
USD 34,914
|
|
|
2024-04-03 |
2024-04-02 |
S
Sale
|
Sandrock Alfred
President and CEO
Executive Director
|
12,115
-3.6%
9.86
USD 119,454
|
12,115
-3.6%
|
9.86
|
USD 119,454
|
|
|
2024-04-03 |
2024-04-02 |
S
Sale
|
Swartz Robin
Chief Operating Officer
Officer
|
1,357
-1.1%
9.88
USD 13,407
|
1,357
-1.1%
|
9.88
|
USD 13,407
|
|
|
2024-02-22 |
2024-02-21 |
S
Sale
|
Sandrock Alfred
President and CEO
Executive Director
|
13,033
-3.7%
7.46
USD 97,226
|
13,033
-3.7%
|
7.46
|
USD 97,226
|
|
|
2024-02-22 |
2024-02-21 |
S
Sale
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Officer
|
3,764
-2.1%
7.46
USD 28,079
|
3,764
-2.1%
|
7.46
|
USD 28,079
|
|
|
2024-02-22 |
2024-02-21 |
S
Sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
3,365
-3.7%
7.47
USD 25,137
|
3,365
-3.7%
|
7.47
|
USD 25,137
|
|
|
2024-02-22 |
2024-02-21 |
S
Sale
|
Swartz Robin
Chief Operating Officer
Officer
|
3,966
-3.2%
7.45
USD 29,547
|
3,966
-3.2%
|
7.45
|
USD 29,547
|
|
|
2024-02-22 |
2024-02-20 |
S
Sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
602
-0.7%
7.68
USD 4,623
|
602
-0.7%
|
7.68
|
USD 4,623
|
|
|
2024-01-19 |
2024-01-17 |
S
Sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
1,266
-2.3%
7.18
USD 9,090
|
1,266
-2.3%
|
7.18
|
USD 9,090
|
|
|
2024-01-19 |
2024-01-17 |
PS
Planned sale
|
Swartz Robin
Chief Operating Officer
Officer
|
2,543
-3.4%
7.15
USD 18,182
|
2,543
-3.4%
|
7.15
|
USD 18,182
|
|
|
2023-10-05 |
2023-10-03 |
S
Sale
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Officer
|
13,567
-8.3%
6.99
USD 94,833
|
13,567
-8.3%
|
6.99
|
USD 94,833
|
|
|
2023-09-18 |
2023-09-15 |
PS
Planned sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
10,500
-16.2%
8.16
USD 85,680
|
10,500
-16.2%
|
8.16
|
USD 85,680
|
|
|
2023-07-10 |
2023-07-06 |
PS
Planned sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
5,500
-8.4%
10.80
USD 59,400
|
5,500
-8.4%
|
10.80
|
USD 59,400
|
|
|
2023-07-05 |
2023-06-30 |
PS
Planned sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
5,000
-7.1%
11.41
USD 57,050
|
5,000
-7.1%
|
11.41
|
USD 57,050
|
|
|
2023-04-05 |
2023-04-03 |
S
Sale
|
Swartz Robin
Chief Operating Officer
Officer
|
1,259
-1.7%
7.83
USD 9,858
|
1,259
-1.7%
|
7.83
|
USD 9,858
|
|
|
2023-04-05 |
2023-04-03 |
S
Sale
|
Sandrock Alfred
President and CEO
Executive Director
|
7,437
-3.3%
7.83
USD 58,232
|
7,437
-3.3%
|
7.83
|
USD 58,232
|
|
|
2023-03-22 |
2023-03-20 |
PS
Planned sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
2,193
-3.2%
7.76
USD 17,018
|
2,193
-3.2%
|
7.76
|
USD 17,018
|
|
|
2023-03-22 |
2023-03-20 |
PS
Planned sale
|
Hesslein Robert W.
Senior VP & General Counsel
Officer
|
4,410
-4.1%
7.76
USD 34,222
|
4,410
-4.1%
|
7.76
|
USD 34,222
|
|
|
2023-03-22 |
2023-03-20 |
PS
Planned sale
|
Swartz Robin
Chief Operating Officer
Officer
|
3,654
-4.8%
7.76
USD 28,355
|
3,654
-4.8%
|
7.76
|
USD 28,355
|
|
|
2023-03-17 |
2023-03-15 |
S
Sale
|
Swartz Robin
Chief Operating Officer
Officer
|
15,373
-16.7%
8.20
USD 126,059
|
15,373
-16.7%
|
8.20
|
USD 126,059
|
|
|
2023-02-24 |
2023-02-23 |
B
Purchase
|
NEUROCRINE BIOSCIENCES INC
Large shareholder
|
4,395,588
+105.2%
8.88
USD 39,032,821
|
4,395,588
+105.2%
|
8.88
|
USD 39,032,821
|
|
|
2023-02-22 |
2023-02-17 |
PS
Planned sale
|
Hesslein Robert W.
Senior VP & General Counsel
Officer
|
3,297
-3.0%
7.45
USD 24,563
|
3,297
-3.0%
|
7.45
|
USD 24,563
|
|
|
2023-02-22 |
2023-02-17 |
PS
Planned sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
738
-1.1%
7.45
USD 5,498
|
738
-1.1%
|
7.45
|
USD 5,498
|
|
|
2023-02-15 |
2023-02-13 |
PS
Planned sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
797
-2.3%
7.67
USD 6,113
|
797
-2.3%
|
7.67
|
USD 6,113
|
|
|
2023-02-15 |
2023-02-13 |
PS
Planned sale
|
Hesslein Robert W.
Senior VP & General Counsel
Officer
|
2,868
-2.5%
7.67
USD 21,998
|
2,868
-2.5%
|
7.67
|
USD 21,998
|
|
|
2023-02-01 |
2023-02-01 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
128,642
-2.7%
9.32
USD 1,198,943
|
128,642
-2.7%
|
9.32
|
USD 1,198,943
|
|
|
2023-02-01 |
2023-01-31 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
185,000
-3.7%
9.25
USD 1,711,250
|
185,000
-3.7%
|
9.25
|
USD 1,711,250
|
|
|
2023-02-01 |
2023-01-30 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
75,000
-1.5%
9.03
USD 677,250
|
75,000
-1.5%
|
9.03
|
USD 677,250
|
|
|
2023-01-31 |
2023-01-27 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
50,000
-1.0%
9.02
USD 451,000
|
50,000
-1.0%
|
9.02
|
USD 451,000
|
|
|
2023-01-26 |
2023-01-25 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
50,000
-1.0%
9.22
USD 461,000
|
50,000
-1.0%
|
9.22
|
USD 461,000
|
|
|
2023-01-26 |
2023-01-24 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
100,000
-1.9%
9.27
USD 927,000
|
100,000
-1.9%
|
9.27
|
USD 927,000
|
|
|
2023-01-24 |
2023-01-23 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
55,000
-1.0%
9.06
USD 498,300
|
55,000
-1.0%
|
9.06
|
USD 498,300
|
|
|
2023-01-24 |
2023-01-20 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
100,000
-1.8%
9.15
USD 915,000
|
100,000
-1.8%
|
9.15
|
USD 915,000
|
|
|
2023-01-19 |
2023-01-17 |
PS
Planned sale
|
Hesslein Robert W.
Senior VP & General Counsel
Officer
|
792
-0.7%
10.34
USD 8,189
|
792
-0.7%
|
10.34
|
USD 8,189
|
|
|
2023-01-19 |
2023-01-17 |
PS
Planned sale
|
Hesslein Robert W.
Senior VP & General Counsel
Officer
|
1,396
-1.2%
9.57
USD 13,360
|
1,396
-1.2%
|
9.57
|
USD 13,360
|
|
|
2023-01-19 |
2023-01-17 |
PS
Planned sale
|
Swartz Robin
Chief Operating Officer
Officer
|
792
-1.5%
10.34
USD 8,189
|
792
-1.5%
|
10.34
|
USD 8,189
|
|
|
2023-01-19 |
2023-01-17 |
PS
Planned sale
|
Swartz Robin
Chief Operating Officer
Officer
|
1,396
-2.6%
9.57
USD 13,360
|
1,396
-2.6%
|
9.57
|
USD 13,360
|
|
|
2023-01-19 |
2023-01-17 |
PS
Planned sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
400
-1.1%
10.34
USD 4,136
|
400
-1.1%
|
10.34
|
USD 4,136
|
|
|
2023-01-19 |
2023-01-17 |
PS
Planned sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
706
-2.0%
9.57
USD 6,756
|
706
-2.0%
|
9.57
|
USD 6,756
|
|
|
2023-01-11 |
2023-01-11 |
S
Sale
|
EcoR1 Capital, LLC
Large shareholder
|
110,000
-2.8%
8.50
USD 934,615
|
110,000
-2.8%
|
8.50
|
USD 934,615
|
|
|
2023-01-11 |
2023-01-10 |
S
Sale
|
EcoR1 Capital, LLC
Large shareholder
|
336,400
-7.8%
8.05
USD 2,709,433
|
336,400
-7.8%
|
8.05
|
USD 2,709,433
|
|
|
2023-01-11 |
2023-01-09 |
S
Sale
|
EcoR1 Capital, LLC
Large shareholder
|
456,000
-9.6%
7.67
USD 3,498,295
|
456,000
-9.6%
|
7.67
|
USD 3,498,295
|
|
|
2023-01-10 |
2023-01-06 |
S
Sale
|
Carter Todd Alfred
Chief Scientific Officer
Officer
|
388
-1.1%
6.41
USD 2,487
|
388
-1.1%
|
6.41
|
USD 2,487
|
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
200,000
-3.6%
6.22
USD 1,244,000
|
200,000
-3.6%
|
6.22
|
USD 1,244,000
|
|
|
2022-08-26 |
2022-08-24 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
149,972
-2.6%
6.09
USD 913,329
|
149,972
-2.6%
|
6.09
|
USD 913,329
|
|
|
2022-08-18 |
2022-08-16 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
128,456
-2.2%
6.04
USD 775,874
|
128,456
-2.2%
|
6.04
|
USD 775,874
|
|
|
2022-08-16 |
2022-08-15 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
135,808
-2.2%
6.04
USD 820,280
|
135,808
-2.2%
|
6.04
|
USD 820,280
|
|
|
2022-08-16 |
2022-08-12 |
S
Sale
|
Third Rock Ventures III, L.P.
Large shareholder
|
348,007
-5.4%
6.12
USD 2,129,803
|
348,007
-5.4%
|
6.12
|
USD 2,129,803
|
|
|
2022-07-18 |
2022-07-14 |
PS
Planned sale
|
PIERCE GLENN
Non-Executive Director
|
9,512
-36.2%
6.70
USD 63,730
|
9,512
-36.2%
|
6.70
|
USD 63,730
|
|
|
2022-07-18 |
2022-07-14 |
PS
Planned sale
|
Higgins Michael J
Non-Executive Director
|
13,891
-30.7%
6.70
USD 93,070
|
13,891
-30.7%
|
6.70
|
USD 93,070
|
|
|
2022-06-23 |
2022-06-23 |
B
Purchase
|
EcoR1 Capital, LLC
Large shareholder
|
376,000
+8.6%
5.66
USD 2,126,543
|
376,000
+8.6%
|
5.66
|
USD 2,126,543
|
|
|
2022-06-23 |
2022-06-21 |
B
Purchase
|
EcoR1 Capital, LLC
Large shareholder
|
101,400
+2.4%
5.28
USD 535,504
|
101,400
+2.4%
|
5.28
|
USD 535,504
|
|
|
2022-04-06 |
2022-04-04 |
PS
Planned sale
|
Swartz Robin
Chief Operating Officer
Officer
|
1,527
-2.8%
8.25
USD 12,598
|
1,527
-2.8%
|
8.25
|
USD 12,598
|
|
|
2022-04-06 |
2022-04-04 |
PS
Planned sale
|
Hesslein Robert W.
Senior VP & General Counsel
Officer
|
2,786
-2.4%
8.25
USD 22,985
|
2,786
-2.4%
|
8.25
|
USD 22,985
|
|
|
2022-03-23 |
2022-03-21 |
PS
Planned sale
|
Swartz Robin
Chief Operating Officer
Officer
|
51
-0.1%
8.68
USD 443
|
51
-0.1%
|
8.68
|
USD 443
|
|
|
2022-03-23 |
2022-03-21 |
PS
Planned sale
|
Swartz Robin
Chief Operating Officer
Officer
|
4,362
-7.5%
8.29
USD 36,161
|
4,362
-7.5%
|
8.29
|
USD 36,161
|
|
|
2022-03-23 |
2022-03-21 |
PS
Planned sale
|
Burek Julie
VP, Finance
Officer
|
31
-0.1%
8.68
USD 269
|
31
-0.1%
|
8.68
|
USD 269
|
|
|
2022-03-23 |
2022-03-21 |
PS
Planned sale
|
Burek Julie
VP, Finance
Officer
|
2,618
-4.8%
8.29
USD 21,703
|
2,618
-4.8%
|
8.29
|
USD 21,703
|
|
|
2022-03-23 |
2022-03-21 |
PS
Planned sale
|
Hesslein Robert W.
Senior VP & General Counsel
Officer
|
58
-0.0%
8.68
USD 503
|
58
-0.0%
|
8.68
|
USD 503
|
|
|
2022-03-23 |
2022-03-21 |
PS
Planned sale
|
Hesslein Robert W.
Senior VP & General Counsel
Officer
|
4,897
-4.0%
8.29
USD 40,596
|
4,897
-4.0%
|
8.29
|
USD 40,596
|
|
|
2022-02-22 |
2022-02-17 |
PS
Planned sale
|
Hesslein Robert W.
Senior VP & General Counsel
Officer
|
4,100
-3.2%
3.55
USD 14,555
|
4,100
-3.2%
|
3.55
|
USD 14,555
|
|
|
2022-02-22 |
2022-02-17 |
PS
Planned sale
|
Burek Julie
VP, Finance
Officer
|
789
-1.4%
3.55
USD 2,801
|
789
-1.4%
|
3.55
|
USD 2,801
|
|
|
2022-02-15 |
2022-02-11 |
PS
Planned sale
|
Hesslein Robert W.
Senior VP & General Counsel
Officer
|
3,252
-2.5%
3.36
USD 10,927
|
3,252
-2.5%
|
3.36
|
USD 10,927
|
|
